Disclosures: Sandeep Yerra, MBBS: No financial relationships or conflicts of interest

Objective: To compare range of motion, pain, and function in patients with chronic refractory Adhesive Capsulitis (AC) after TENEX® ultrasound (US) guided Coracohumeral Ligament (CHL) release vs control

Design: Randomized Controlled Trial

Setting: Outpatient Pain Clinic

Participants: 48 subjects (39 female, 9 male) with chronic AC refractory to PT and local steroid injection

Interventions: Patients were randomly assigned to percutaneous CHL release and CHL LA injection control

Main Outcome Measures: Pre/post-procedure external rotation and abduction were the primary outcome measures and VAS (Visual analogue Pain Scale) was secondary

Results: At one month follow-up mean pre-procedure VAS was 8.1 and the mean post-procedure VAS was 2.7. In addition, the average pre-procedure external rotation was doubled at one month from 30.15 degrees to 59.4 degrees. Likewise, pre-procedure abduction was 58.2 and 74.4 degrees at one month follow-up. There were no adverse events.

Conclusions: Percutaneous US-guided CHL release with a TENEX® tissue remodeling tool improved pain, function, and ROM at one-month FUP. However, longer-term durability needs to be assessed to understand the true clinical importance of the procedure

Level of Evidence: Level I

« Back to AAPM&R Annual Assembly 2022

PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/percutaneous-sectioning-of-the-coracohumeral-ligament-for-the-treatment-of-refractory-adhesive-capsulitis-a-randomized-clinical-trial-with-functional-outcomes/